Charles Stein “We like outsourcing the asset-allocation decision to someone who does a good job of it,” said Steven Roge, a portfolio manager at R.W. Roge & Co., and an investor in FPA Crescent. Roge, whose Bohemia, New York, firm oversees about $200 million, said Romick has shown he can handle the freedom. Read MoreRead More

The second quarter can be best characterized by extreme volatility.  Despite all of the volatility, our portfolios held up remarkably well, when compared to the market.  Most of our portfolios were down in the 1% to 5% range compared to an almost 12% drop in the S&P 500 stock market index during the second quarter. We view...Read More

My son Steve and I recently spent a week in Chicago meeting and interviewing investment managers at The Sincere & Co. Annual Education Symposium and the annual Morningstar Conference for Investment Advisors. This trip gave us the opportunity to have lengthy meetings and several dinners with managers of funds we currently hold in our portfolios.  Most...Read More

Alexandra Zendrian R.W. Roge portfolio manager Steven Roge says investors shouldn’t invest in coal as the push toward alternative energy bodes better for natural gas and will create headwinds for coal electricity going forward. Read MoreRead More

Jeff Benjamin “There are some midtier biotech firms with terrific pipelines,” said Steven Roge, a portfolio manager with R.W. Roge & Co. Inc., which has $200 million under management. For example, he estimates Genzym’s fair-value price to be about $55, or about $5 above its current share price. “A larger company might pay $70 or...Read More